Impact of a Synbiotic Containing Fructo-oligosaccharides and Bifidobacteria in Middle-aged Adults

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 12, 2016

Primary Completion Date

October 29, 2018

Study Completion Date

January 31, 2019

Conditions
Constipation
Interventions
DIETARY_SUPPLEMENT

Synbiotic

Middle-aged subjects, who met ROME III criteria for constipation, received daily two sachets of synbiotic (Bifidobaterium animalis lactis Vesalius 002 and Fructo-Oligosaccharrides) for 5 days, then they received daily 1 sachet for the next 25 days

DIETARY_SUPPLEMENT

Placebo

Middle-aged subjects, who met ROME III criteria for constipation, received daily two sachets of placebo (maltodextrin and sucrose) for 5 days, then they received daily 1 sachet for the next 25 days

All Listed Sponsors
collaborator

Université Catholique de Louvain

OTHER

collaborator

University of Liege

OTHER

lead

Vesale Pharmaceutica

INDUSTRY

NCT04283266 - Impact of a Synbiotic Containing Fructo-oligosaccharides and Bifidobacteria in Middle-aged Adults | Biotech Hunter | Biotech Hunter